Feasibility Study of Dendrimer-Based TTR-CRISPR pDNA Polyplex for Ocular Amyloidosis <i>in Vitro</i>-Reference-Cited by-同舟云学术

Feasibility Study of Dendrimer-Based TTR-CRISPR pDNA Polyplex for Ocular Amyloidosis <i>in Vitro</i>

Published:2022-11-01 Issue:11 Volume:45 Page:1660-1668
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Inoue Masamichi¹,Muta Kyosuke¹,Mohammed Ahmed Fouad Abdelwahab¹,Onodera Risako¹,Higashi Taishi²,Ouchi Kenta³,Ueda Mitsuharu⁴,Ando Yukio⁵,Arima Hidetoshi⁶,Jono Hirofumi³,Motoyama Keiichi¹

Affiliation:

1. Department of Physical Pharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University

2. Priority Organization for Innovation and Excellence, Kumamoto University

3. Department of Clinical Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Kumamoto University

4. Department of Neurology, Graduate School of Medical Sciences, Kumamoto University

5. Department of Amyloidosis Research, Nagasaki International University

6. Laboratory of Evidence-Based Pharmacotherapy, Daiichi University of Pharmacy

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/45/11/45_b22-00452/_pdf

Reference37 articles.

1. 1) Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl. Neurodegener., 3, 19 (2014).

2. 2) Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch. Neurol., 62, 1057–1062 (2005).

3. 3) Gasperini RJ, Klaver DW, Hou X, Aguilar MI, Small DH. Mechanisms of transthyretin aggregation and toxicity. Subcell. Biochem., 65, 211–224 (2012).

4. 4) Saelices L, Johnson LM, Liang WY, Sawaya MR, Cascio D, Ruchala P, Whitelegge J, Jiang L, Riek R, Eisenberg DS. Uncovering the mechanism of aggregation of human transthyretin. J. Biol. Chem., 290, 28932–28943 (2015).

5. 5) Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Arch. Ophthalmol., 128, 206–210 (2010).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Patisiran Reduce Ocular Transthyretin Synthesis? A Pilot Study of Two Cases;Current Neuropharmacology;2023-12

2. Hereditary transthyretin amyloid neuropathies: advances in pathophysiology, biomarkers, and treatment;The Lancet Neurology;2023-11

3. Overview of Recent Advances in Nano-Based Ocular Drug Delivery;International Journal of Molecular Sciences;2023-10-19

4. Functional Peptide-Modified Liposomes for siRNA Delivery to Rat Retinal Pigment Epithelium Cells: Effect of Peptide Sequences;Biological and Pharmaceutical Bulletin;2023-10-01